Showing results (161-170 of 287) with videos related to

Sort By:
Pageof 29
American Heart Journal|October 3, 2002
Effectiveness of a multidisciplinary chest pain unit for the assessment of coronary syndromes and risk stratification in the Florence areaAlberto Conti, Barbara Paladini, Simone Toccafondi, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|September 2, 2008
Relationship of sustained brain natriuretic peptide release after reperfused acute myocardial infarction with gated SPECT infarct measurements and its connection with collagen turnover and left ventricular remodelingGiampaolo Cerisano, Renato Valenti, Roberto Sciagrà, et al.
European Journal of Clinical Investigation|April 8, 2023
Prognostic role of CRP-independent inflammatory patterns in patients undergoing primary percutaneous interventionsFilippo Dossi, Mario Raccis, Guido Parodi, et al.
The American Journal of Cardiology|May 18, 2012
Meta-analysis comparing bivalirudin versus heparin monotherapy on ischemic and bleeding outcomes after percutaneous coronary interventionOlivier F Bertrand, Sanjit S Jolly, Sunil V Rao, et al.
European Heart Journal|January 26, 2007
Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-upGilles Montalescot, David Antoniucci, Adnan Kastrati, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 5, 2017
Incidence and outcome of switching of oral platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: the SCOPE registryLeonardo De Luca, Fabrizio D'Ascenzo, Giuseppe Musumeci, et al.
Clinical Pharmacokinetics|August 29, 2015
Crushed Versus Integral Tablets of Ticagrelor in ST-Segment Elevation Myocardial Infarction Patients: A Randomized Pharmacokinetic/Pharmacodynamic StudyDimitrios Alexopoulos, Nikolaos Barampoutis, Vasileios Gkizas, et al.
Thrombosis and Haemostasis|May 29, 2010
High on-treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stentingRossella Marcucci, Anna Maria Gori, Rita Paniccia, et al.
Circulation|January 2, 2009
Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-upRossella Marcucci, Anna Maria Gori, Rita Paniccia, et al.
The American Journal of Cardiology|March 10, 2009
Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosisBetti Giusti, Anna Maria Gori, Rossella Marcucci, et al.
Pageof 29